The primary mechanism through which catalysts enhance radiotherapy is by generating reactive oxygen species (ROS) when exposed to radiation. These ROS are highly reactive and can cause significant damage to the DNA of cancer cells, leading to their death. Metal-based catalysts, such as those containing gold or platinum, are particularly effective in this regard. These catalysts can be targeted specifically to cancer cells, ensuring that the enhanced radiation effect is localized.
